angiotensin ii, des-phe(8)- has been researched along with Cancer of Esophagus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YH; Hsiao, CC; Huang, CC; Li, SH; Lo, CM; Lu, HI | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and Cancer of Esophagus
| Article | Year |
|---|---|
The clinical impact of angiotensin-(1-7)/mitochondrial assembly receptor axis in esophageal squamous cell carcinoma patients receiving curative esophagectomy.
Topics: Adult; Aged; Angiotensin I; Biomarkers, Tumor; Cell Line, Tumor; Disease-Free Survival; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Peptide Fragments; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Retrospective Studies; Risk Factors; Treatment Outcome | 2020 |